Search Results 261-270 of 16360 for monoclonal antibody

1. Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme - Mayo Clinic

   Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

2. Pozelimab-bbfg (intravenous route, subcutaneous route) - Mayo Clinic

   This medicine is a monoclonal antibody that works on the immune system. This medicine is to be given only by or under the direct supervision of your doctor ...

3. Medulloblastoma Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

4. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

   Monoclonal antibodies, such as atezolizumab, may block specific proteins found on white blood cells which may strengthen the immune system and control tumor ...

5. Acute Lymphocytic Leukemia Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as blinatumomab, may block cancer growth in different ways by targeting certain cells. It is not yet known whether combination ...

6. Trastuzumab-strf (intravenous route) - Mayo Clinic

   Trastuzumab-strf is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

7. Infliximab-qbtx (intravenous route) - Mayo Clinic

   Infliximab-qbtx is a monoclonal antibody that works to enhance and improve the immune system. This medicine is to be given only by or under the direct ...

8. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

9. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as alemtuzumab, can bind to and kill malignant lymphocytes. PURPOSE: This phase I/II trial is studying the side effects and best ...

10. Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma - Mayo Clinic

    Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found in greater than normal amounts on some types of cancer cells. This ...